Harvard Bioscience (NASDAQ:HBIO) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Harvard Bioscience missed estimated earnings by 20.0%, reporting an EPS of $0.08 versus an estimate of $0.1.
Revenue was up $2.07 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 2.05% increase in the share price the next day.
Here's a look at Harvard Bioscience's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.06 | 0.06 | 0.03 | 0.06 |
| EPS Actual | 0.06 | 0.06 | 0.05 | 0.08 |
| Revenue Estimate | 27.91M | 27.67M | 25.73M | 27.13M |
| Revenue Actual | 29.66M | 29.20M | 26.99M | 30.98M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
